Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.

Atkinson RJ, Fulham WR, Michie PT, Ward PB, Todd J, Stain H, Langdon R, Thienel R, Paulik G, Cooper G; MinT Consortium., Schall U.

PLoS One. 2017 Feb 10;12(2):e0171657. doi: 10.1371/journal.pone.0171657. eCollection 2017.

2.

Clinical significance of auditory target P300 subcomponents in psychosis: Differential diagnosis, symptom profiles, and course.

Perlman G, Foti D, Jackson F, Kotov R, Constantino E, Hajcak G.

Schizophr Res. 2015 Jul;165(2-3):145-51. doi: 10.1016/j.schres.2015.04.013. Epub 2015 Apr 29.

3.

Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, MacDonald ML, Moyer CE, DiBitetto JV, Dorph-Petersen KA, Penzes P, Lewis DA, Sweet RA.

Biol Psychiatry. 2015 Sep 15;78(6):374-85. doi: 10.1016/j.biopsych.2014.12.029. Epub 2015 Jan 30.

4.

Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Light GA, Swerdlow NR.

Ann N Y Acad Sci. 2015 May;1344:105-19. doi: 10.1111/nyas.12730. Epub 2015 Mar 9. Review.

5.

The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study.

Chitty KM, Lagopoulos J, Kaur M, Hickie IB, Hermens DF.

Int J Neuropsychopharmacol. 2015 Jan 20;18(6). pii: pyu113. doi: 10.1093/ijnp/pyu113.

6.

Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients.

Hay RA, Roach BJ, Srihari VH, Woods SW, Ford JM, Mathalon DH.

Biol Psychol. 2015 Feb;105:130-7. doi: 10.1016/j.biopsycho.2015.01.004. Epub 2015 Jan 17.

7.

Clinical high risk and first episode schizophrenia: auditory event-related potentials.

del Re EC, Spencer KM, Oribe N, Mesholam-Gately RI, Goldstein J, Shenton ME, Petryshen T, Seidman LJ, McCarley RW, Niznikiewicz MA.

Psychiatry Res. 2015 Feb 28;231(2):126-33. doi: 10.1016/j.pscychresns.2014.11.012. Epub 2014 Nov 29.

8.

Cortical thinning in young psychosis and bipolar patients correlate with common neurocognitive deficits.

Hatton SN, Lagopoulos J, Hermens DF, Scott E, Hickie IB, Bennett MR.

Int J Bipolar Disord. 2013 Apr 17;1:3. doi: 10.1186/2194-7511-1-3. eCollection 2013.

9.

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Light GA, Swerdlow NR, Thomas ML, Calkins ME, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Pela M, Radant AD, Seidman LJ, Sharp RF, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Braff DL, Turetsky BI.

Schizophr Res. 2015 Apr;163(1-3):63-72. doi: 10.1016/j.schres.2014.09.042. Epub 2014 Oct 23.

10.

Cortical substrates and functional correlates of auditory deviance processing deficits in schizophrenia.

Rissling AJ, Miyakoshi M, Sugar CA, Braff DL, Makeig S, Light GA.

Neuroimage Clin. 2014 Oct 1;6:424-37. doi: 10.1016/j.nicl.2014.09.006. eCollection 2014.

11.

Biomarkers and clinical staging in psychiatry.

McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I.

World Psychiatry. 2014 Oct;13(3):211-23. doi: 10.1002/wps.20144.

12.

White matter tractography in early psychosis: clinical and neurocognitive associations.

Hatton SN, Lagopoulos J, Hermens DF, Hickie IB, Scott E, Bennett MR.

J Psychiatry Neurosci. 2014 Nov;39(6):417-27.

13.

Mismatch negativity in recent-onset and chronic schizophrenia: a current source density analysis.

Fulham WR, Michie PT, Ward PB, Rasser PE, Todd J, Johnston PJ, Thompson PM, Schall U.

PLoS One. 2014 Jun 20;9(6):e100221. doi: 10.1371/journal.pone.0100221. eCollection 2014.

14.

Mismatch negativity (MMN) as an index of cognitive dysfunction.

Näätänen R, Sussman ES, Salisbury D, Shafer VL.

Brain Topogr. 2014 Jul;27(4):451-66. doi: 10.1007/s10548-014-0374-6. Epub 2014 May 17. Review.

15.

Mismatch negativity latency and cognitive function in schizophrenia.

Kärgel C, Sartory G, Kariofillis D, Wiltfang J, Müller BW.

PLoS One. 2014 Apr 16;9(4):e84536. doi: 10.1371/journal.pone.0084536. eCollection 2014.

16.

A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation.

Aas M, Dazzan P, Mondelli V, Melle I, Murray RM, Pariante CM.

Front Psychiatry. 2014 Jan 8;4:182. doi: 10.3389/fpsyt.2013.00182. Review.

17.

Mismatch negativity: translating the potential.

Todd J, Harms L, Schall U, Michie PT.

Front Psychiatry. 2013 Dec 18;4:171. doi: 10.3389/fpsyt.2013.00171. Review.

18.

Contributions of experimental psychiatry to research on the psychosis prodrome.

Bodatsch M, Klosterkötter J, Daumann J.

Front Psychiatry. 2013 Dec 17;4:170. doi: 10.3389/fpsyt.2013.00170. Review.

19.

Auditory event-related potentials and α oscillations in the psychosis prodrome: neuronal generator patterns during a novelty oddball task.

Kayser J, Tenke CE, Kroppmann CJ, Alschuler DM, Fekri S, Ben-David S, Corcoran CM, Bruder GE.

Int J Psychophysiol. 2014 Feb;91(2):104-20. doi: 10.1016/j.ijpsycho.2013.12.003. Epub 2013 Dec 13.

20.

Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Perez VB, Swerdlow NR, Braff DL, Näätänen R, Light GA.

Biomark Med. 2014;8(1):9-14. doi: 10.2217/bmm.13.133. No abstract available.

Supplemental Content

Support Center